Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Africa must participate in finding a gene therapy cure for sickle-cell disease

Nature Medicine volume 28, pages 2451–2452 (2022)Cite this article

Subjects

Sickle-cell disease (SCD) is the most common serious inherited disease, with 300,000 affected individuals born yearly worldwide, with three-quarters of them in Africa.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kato, G. J. et al. Nat. Rev. Dis. Primers 4, 18010 (2018).

    Article  Google Scholar 

  2. Tshilolo, L. et al. N. Engl. J. Med. 380, 121–131 (2019).

    Article  CAS  Google Scholar 

  3. Luzzatto, L. et al. Front. Pharmacol. 12, 770640 (2021).

    Article  CAS  Google Scholar 

  4. Faulkner, L. et al. Bone Marrow Transplant. 56, 536–543 (2021).

    Article  Google Scholar 

  5. WHO. https://www.who.int/news/item/12-07-2022-who-s-science-council-launches-report-calling-for-equitable-expansion-of-genomics (accessed September 2022).

  6. Nathwani, A. C. et al. N. Engl. J. Med. 365, 2357–2365 (2011).

    Article  CAS  Google Scholar 

  7. Gillmore, J. D. et al. N. Engl. J. Med. 385, 493–502 (2021).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank L. Luzzatto for his contribution in the preparation of this correspondence.

Author information

Authors and Affiliations

  1. Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences (MUHAS), Dar-es-Salaam, Tanzania

    Grace Moshi & Julie Makani

  2. Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital Singapore, Duke-NUS Medical School, Singapore, Singapore

    Grace Moshi

  3. Department of Pediatrics, Division of Pediatric Hematology/Oncology, Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA

    Vivien A. Sheehan

  4. Sickle Cell Programme, Department of Haematology and Blood Transfusion, School of Medicine, MUHAS, Dar-es-Salaam, Tanzania

    Julie Makani

  5. Sickle Pan-African Consortium (SPARCO) Clinical Coordinating Centre, SickleInAfrica, Muhimbili University of Health and Allied Sciences (MUHAS), Dar-es-Salaam, Tanzania

    Julie Makani

Authors
  1. Grace Moshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivien A. Sheehan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julie Makani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie Makani.

Ethics declarations

Competing interests

All authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moshi, G., Sheehan, V.A. & Makani, J. Africa must participate in finding a gene therapy cure for sickle-cell disease. Nat Med 28, 2451–2452 (2022). https://doi.org/10.1038/s41591-022-02033-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-022-02033-5

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing